Amgen to buy Turkish drugmaker for $700 million
By Ben Hirschler
LONDON | Wed Apr 25, 2012 3:49am EDT
(Reuters) - U.S. biotech company Amgen is to buy Turkey's Mustafa Nevzat Pharmaceuticals, a maker of injectable generic drugs, for around $700 million in a deal underscoring Western drugmakers' thirst for emerging markets sales.
More:Amgen to buy Turkish drugmaker for $700 million | Reuters
